OrbiMed’s Xylo Technologies XYLO Stock Holding History

OrbiMed’s Portfolio XYLO Stock Details XYLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-375	Closed	-$26K	–	163
2019 Q4	$26K	Hold	375	–	–	﹤0.01%	136
2019 Q3	$26K	Hold	375	–	–	﹤0.01%	116
2019 Q2	$37K	Hold	375	–	–	﹤0.01%	128
2019 Q1	$44K	Hold	375	–	–	﹤0.01%	124
2018 Q4	$39K	Hold	375	–	–	﹤0.01%	131
2018 Q3	$51K	Hold	375	–	–	﹤0.01%	150
2018 Q2	$74K	Hold	375	–	–	﹤0.01%	147
2018 Q1	$76K	Hold	375	–	–	﹤0.01%	141
2017 Q4	$79K	Hold	375	–	–	﹤0.01%	133
2017 Q3	$134K	Hold	375	–	–	﹤0.01%	142
2017 Q2	$131K	Hold	375	–	–	﹤0.01%	138
2017 Q1	$185K	Hold	375	–	–	﹤0.01%	136
2016 Q4	$339K	Hold	375	–	–	﹤0.01%	129
2016 Q3	$756K	Hold	375	–	–	0.01%	133
2016 Q2	$1.09M	Hold	375	–	–	0.01%	125
2016 Q1	$1.61M	Hold	375	–	–	0.02%	131
2015 Q4	$52K	Hold	375	–	–	﹤0.01%	130
2015 Q3	$2.69M	Buy	+375	New	+$2.49M	0.03%	122

Other funds holding XYLO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

OrbiMed's XYLO Position: Q1 2020 in Review

OrbiMed sold out of Xylo Technologies (XYLO) in Q1 2020, closing a stake of 375 shares — an estimated $26K sold.

OrbiMed first reported a position in XYLO in Q3 2015 and held it in 18 quarters. The position peaked at $2.69M in Q3 2015. 3 funds tracked by Wall St. Rank hold XYLO as of Q1 2020.

OrbiMed reported no remaining Xylo Technologies position as of Q1 2020 after selling out during the quarter.
OrbiMed sold 375 Xylo Technologies shares in Q1 2020, an estimated $26K.
OrbiMed first reported a position in Xylo Technologies in Q3 2015 and held it in 18 quarters.
OrbiMed's Xylo Technologies position peaked at $2.69M in Q3 2015.
3 funds tracked by Wall St. Rank held Xylo Technologies as of Q1 2020.

Based on OrbiMed's 13F filing for Q1 2020, filed 15 May 2020.